Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Personnel

Health Fidelity Expands Commercial Team to Support Accelerated Growth


Health Fidelity Inc., a company that provides innovative risk capture solutions for the value-based care era, has expanded its commercial team to support increasing demand for its Lumanenttm suite of risk adjustment solutions.

The San Mateo-based company has added Abby Bilyeu as SVP of client development. In this capacity, Abby will lead Health Fidelity's solution architect, sales, and account management functions across the payer and provider segments.

Robin Lloyd, chief commercial officer of Health Fidelity, noted, "Abby's healthcare experience and track record of driving successful, long-term client relationships made her a natural fit for Health Fidelity. Despite the impact of COVID-19 on providers, demand for solutions that ensure complete and accurate capture of risk adjustable conditions remains strong. By expanding our team now, we stand ready to help a growing set of organizations thrive in risk-based payment models and deliver better care to the populations they cover."

Bilyeu's experience in healthcare includes McKesson, Change Healthcare, and Netsmart Technologies, covering business development, client relations, marketing, and operations.

To learn more, follow @healthfidelity on Twitter or visit our website, healthfidelity.com.

About Health Fidelity

Health Fidelity simplifies risk adjustment, offering risk-bearing organizations clear visibility into and control over the process. Through our NLP-powered solutions and expert advisory services, we uncover insights that enable better care plans and more complete revenue capture. The Lumanenttm suite gives our partners the confidence to pursue and ability to succeed in risk-sharing arrangements across MA, ACA, Medicaid, and ACO programs.

Health Fidelity is a registered trademark of Health Fidelity, Inc.


These press releases may also interest you

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...



News published on and distributed by: